Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity
Open Access
- 19 April 2016
- journal article
- review article
- Published by Springer Nature in Translational Psychiatry
- Vol. 6 (4) , e785
Abstract
Schizophrenia (SCZ) and type 2 diabetes (T2D) are clinically associated, and common knowledge attributes this association to side effects of antipsychotic treatment. However, even drug-naive patients with SCZ are at increased risk for T2D. Dopamine dysfunction has a central role in SCZ. It is well-known that dopamine constitutively inhibits prolactin (PRL) secretion via the dopamine receptor 2 (DR2D). If dopamine is increased or if dopamine receptors hyperfunction, PRL may be reduced. During the first SCZ episode, low PRL levels are associated with worse symptoms. PRL is essential in human and social bonding, as well as it is implicated in glucose homeostasis. Dopamine dysfunction, beyond contributing to SCZ symptoms, may lead to altered appetite and T2D. To our knowledge, there are no studies of the genetics of the SCZ–T2D comorbidity focusing jointly on the dopamine and PRL pathway in the attempt to capture molecular heterogeneity correlated to possible disease manifestation heterogeneity. In this dopamine–PRL pathway-focused-hypothesis-driven review on the association of SCZ with T2D, we report a specific revision of what it is known about PRL and dopamine in relation to what we theorize is one of the missing links between the two disorders. We suggest that new studies are necessary to establish the genetic role of PRL and dopamine pathway in SCZ–T2D comorbidity.Keywords
This publication has 136 references indexed in Scilit:
- Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?BMC Endocrine Disorders, 2013
- The thrifty phenotype hypothesis revisitedDiabetologia, 2012
- Pharmacologic Rescue of Motivational Deficit in an Animal Model of the Negative Symptoms of SchizophreniaBiological Psychiatry, 2011
- The tempted brain eats: Pleasure and desire circuits in obesity and eating disordersBrain Research, 2010
- Relative food preference and hedonic judgments in schizophreniaPsychiatry Research, 2010
- Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non‐synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopmentAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009
- D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetesNutrition, 2009
- Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factorsNeuroImage, 2008
- Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15Atherosclerosis, 2008
- Parental history of Type 2 diabetes in patients with nonaffective psychosisSchizophrenia Research, 2007